Stephen A Sherwin sold $1.6M of Neurocrine Biosciences (NBIX)

Executed Feb 13 2025, disclosed Feb 14 2025, 1 day later.

Value, as filed

$1.6M

13,831 sh × $116.69

Executed

Feb 13 2025

the trade date, as filed

Disclosed

Feb 14 2025

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

SS Stephen A Sherwin Director profile →

Stephen A Sherwin (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Neurocrine Biosciences, Inc. (NBIX). The largest single filing was $4.1M of NBIX (25,000 sh across 5 lots, as filed), executed Jun 5.

The name

NBIX Neurocrine Biosciences, Inc. NBIX · Healthcare · 59 filings in 24 months ticker →

Healthcare · Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunolog…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Stephen A Sherwin in NBIX

NBIXSALE Neurocrine Biosciences, Inc. $4.1M
25,000 sh across 5 lots
Exec Jun 5
Filed Jun 9 · 5:30 PM ET